-+ 0.00%
-+ 0.00%
-+ 0.00%
Citigroup: Raising CSPC Group's (01093) target price to HK$15 to maintain “buy” rating
Share
Listen to the news

The Zhitong Finance App learned that Citi released a research report saying that the third quarter results of CSPC Group (01093) beat expectations, benefiting from the recovery of authorized revenue and core business. The bank raised its target price from HK$14.6 to HK$15, maintaining a “buy” rating.

The bank believes that the recovery in core drug sales, improved cost efficiency, and the increasing normalization of revenue from business development milestones are beneficial to profit visibility. Central Nervous System (CNS) business revenue increased 29.1% year-on-year in the first nine months, accounting for about 48% of proprietary drug sales after approval was removed. Management expects more than 10 new products and indications to be launched next year to support overall positive growth.

The bank raised its 2026 revenue forecast by 2% and raised its 2026 net profit forecast by 3% due to higher profit margin assumptions, while fine-tuning the 2027 and 2028 forecasts.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending